Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th
Sight Sciences (Nasdaq: SGHT) will present at the 25th Annual Needham Healthcare Conference on Monday, April 13, 2026 at 11:15 am PT / 2:15 pm ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Sight Sciences (Nasdaq: SGHT) will present at the 25th Annual Needham Healthcare Conference on Monday, April 13, 2026 at 11:15 am PT / 2:15 pm ET. Management will deliver a fireside chat available via live and archived webcast.
Investors can access the webcast on the company’s Investors website for a live stream and later replay.
Details
News Market Reaction – SGHT
On Mar 31, the first trading day after this news, SGHT closed 2.45% above the previous close.
Data tracked by StockTitan Argus for the Mar 31 session.
Key Figures
- Conference date
- April 13, 2026
- 25th Annual Needham Healthcare Conference presentation date
- Presentation time PT
- 11:15 am PT
- Scheduled SGHT management presentation time
- Presentation time ET
- 2:15 pm ET
- Scheduled SGHT management presentation time
- Conference edition
- 25th Annual
- Edition of Needham Healthcare Conference
Historical Context
-
Q4 and FY 2025 results with high margins and 2026 guidance issued.
-
Announcement of timing for Q4 and full‑year 2025 earnings call.
-
Preliminary Q4 and FY 2025 revenue, dry eye trends, and cash use update.
-
Peer‑reviewed publications on OMNI system showing IOP and med reductions.
-
Q3 2025 results with higher margins and raised 2025 revenue guidance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today announced plans to present at the 25th Annual Needham Healthcare Conference being held virtually.
Sight Sciences’ management is scheduled to present on Monday, April 13, 2026, at 11:15 am PT / 2:15 pm ET. Interested parties may access a live and archived webcast of the fireside chat on the “Investors” section of the Company’s website at https://investors.sightsciences.com/.
About Sight Sciences
Sight Sciences is an eyecare technology company focused on developing and commercializing innovative and interventional solutions intended to transform care and improve patients’ lives. Using minimally invasive or non-invasive approaches to target the underlying causes of the world’s most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that enhance patient care and supplant conventional outdated approaches. The Company’s OMNI® Surgical System and OMNI® Edge Surgical System are implant-free, minimally invasive glaucoma surgery technologies indicated in the United States to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The OMNI Surgical System is CE Marked for the catheterization and transluminal viscodilation of Schlemm’s canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma. Glaucoma is the world’s leading cause of irreversible blindness. The SION® Surgical System is a bladeless, manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The Company’s TearCare® System is 510(k) cleared in the United States for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the leading cause of dry eye disease. Visit www.sightsciences.com for more information.
Sight Sciences and TearCare are trademarks of Sight Sciences registered in the United States. OMNI, SION, SmartLids, and the Sight Sciences logo are trademarks of Sight Sciences registered in the United States, European Union and other territories.
© 2026 Sight Sciences. All rights reserved.
Media contact:
pr@sightsciences.com
Investor contact:
Philip Taylor
Gilmartin Group
415.937.5406
investor.relations@sightsciences.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.